Minretumomab Biosimilar, TAG-72 Monoclonal Antibody | C033P
$250.00 – $2,000.00
Minretumomab Biosimilar, TAG-72 Monoclonal Antibody. The research grade Minretumomab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
- Details & Specifications
- References
- More Offers
Catalog No. | C033P |
---|---|
Product Name | Minretumomab Biosimilar, TAG-72 Monoclonal Antibody | C033P |
Supplier Name | Syd Labs, Inc. |
Brand Name | Syd Labs |
Synonyms | Tumor-associated glycoprotein 72, TAG-72 |
Summary | Recombinant Humanized IgG1 Monoclonal Antibody. |
Isotype | Human IgG1 kappa. |
Source/Host | The anti-human TAG-72 monoclonal antibody minretumomab biosimilar was produced in mammalian cells. |
Specificity/Sensitivity | The in vivo grade minretumomab biosimilar specifically binds to the human TAG-72 protein. |
Form Of Antibody | 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives. |
Endotoxin | <1 EU/mg of the protein by the LAL method. |
Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
Shipping | The research grade minretumomab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
Note | The research grade Minretumomab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator. |
Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C035P |
C033P: Minretumomab Biosimilar, TAG-72 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Background
Minretumomab Biosimilar uses the same protein sequences as the therapeutic antibody minretumomab.
Minretumomab is a mouse monoclonal antibody that was designed for the treatment of cancers that express the TAG-72 antigen. This includes breast, colon, lung, and pancreatic cancers.
A wide range of derivatives has been used in pharmaceutical research. Examples include chimeric and humanized minretumomab, as well as a fusion protein of a minretumomab single-chain variable fragment and the enzyme beta-lactamase.
Please remember our product information: Minretumomab Biosimilar, TAG-72 Monoclonal Antibody: C033P Syd Labs